![](https://www.diabetesnews.com/wp-content/uploads/2014/06/insulin-1-3c0e963869bf5abd8a8bba77ccf1818be51f46ac-s40-c85-150x150.jpg)
Insulin is the mainstay treatment for patients with type 2 diabetes who also have beta-cell failure; however, some insulin regimens can be complicated to manage and may increase the risk of hypoglycemia. Now, researchers say that a simple add-on therapy with the GLP-1 Agonist medication albiglutide can reduce insulin use for patients with type 2 diabetes. Read more